NIM
NXG Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,821
| Closed | -$411K | – | 75 |
|
|
2022
Q2 | $411K | Sell |
2,821
-2,699
| -49% | -$393K | 0.04% | 75 |
|
|
2022
Q1 | $901K | Sell |
5,520
-301
| -5% | -$49.1K | 0.08% | 60 |
|
|
2021
Q4 | $987K | Sell |
5,821
-383
| -6% | -$64.9K | 0.1% | 69 |
|
|
2021
Q3 | $1.17M | Sell |
6,204
-141
| -2% | -$26.6K | 0.11% | 61 |
|
|
2021
Q2 | $1.08M | Sell |
6,345
-160
| -2% | -$27.1K | 0.1% | 71 |
|
|
2021
Q1 | $918K | Buy |
6,505
+1,448
| +29% | +$204K | 0.1% | 86 |
|
|
2020
Q4 | $657K | Buy |
5,057
+89
| +2% | +$11.6K | 0.07% | 94 |
|
|
2020
Q3 | $723K | Buy |
4,968
+68
| +1% | +$9.9K | 0.1% | 70 |
|
|
2020
Q2 | $726K | Sell |
4,900
-637
| -12% | -$94.4K | 0.08% | 75 |
|
|
2020
Q1 | $603K | Sell |
5,537
-1,169
| -17% | -$127K | 0.08% | 65 |
|
|
2019
Q4 | $772K | Buy |
6,706
+99
| +1% | +$11.4K | 0.04% | 86 |
|
|
2019
Q3 | $531K | Buy |
+6,607
| New | +$531K | 0.03% | 96 |
|